Refractory Acute Myeloid Leukemia Clinical Trials in Middletown, New Jersey

3 studies are recruiting for refractory acute myeloid leukemia in Middletown, New Jersey right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

    The purpose of this study is to find out whether CD371-YSNVZ-IL18 CAR T cells are safe, and to look for the highest dose of CD371-YSNVZ-IL18 CAR T cells that cause few or mild side effects in participants.

    Stage
    Phase 1
    Ages
    1 and older
    Site
    Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown, New Jersey
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center
  2. A Study of CRD3874-SI in People With Leukemia

    The purpose of this study is to find out whether CRD3874-SI is a safe treatment for participants with acute myeloid leukemia (AML).

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Monmouth (All protocol activities), Middletown, New Jersey
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center
  3. Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

    This phase I trial tests the safety, side effects, and best dose of SM08502 (cirtuvivint) alone and in combination with ASTX727 in treating patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Cirtuvivint may stop the growth of cancer cells by blocking some of the enzymes…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Memorial Sloan Kettering Monmouth, Middletown, New Jersey
    Locations
    22 in total
    Run by
    National Cancer Institute (NCI)

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.